The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?
Abstract
Drug-induced liver injury (DILI) is a potentially fatal adverse event and the leading cause of acute liver failure in the US and in the majority of Europe. The liver can be affected directly, in a dose-dependent manner, or idiosyncratically, independently of the dose, and therefore unpredictably. Currently, DILI is a diagnosis of exclusion that physicians should suspect in patients with unexplained elevated liver enzymes. Therefore, new diagnostic and prognostic biomarkers are necessary to achieve an early and reliable diagnosis of DILI and thus improve the prognosis. Although several DILI biomarkers have been found through analytical and genetic tests and pharmacokinetic approaches, none of them have been able to display enough specificity and sensitivity, so new approaches are needed. In this sense, metabolomics is a strongly and promising emerging field that, from biofluids collected through minimally invasive procedures, can obtain early biomarkers of toxicity, which may constitute specific indicators of liver damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Adult humans are characterized by individual metabolic phenotypes [37,38,39,40,41]; there are areas of the metabolome unique to each individual that remain stable over time. “Metabolic profiles” can be detected that allow us to predict which individuals may present ways of metabolizing drugs that make them more susceptible to presenting DILI [17].”
From Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM (2023) · cites this paper as [17]
In the citing paper
“Although some preliminary exploratory research has been conducted [16,17,18], little use has been made of this technique in the study of hepatotoxicity in adults, with no studies in children.”
From Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM (2023) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Pharmaco-metabonomic phenotyping and personalized drug treatment
Andrew Clayton, T., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R. J., et al. (2006) · Nature · doi:10.1038/nature04648 · Cited by 824
Metabolomics and systems biology: making sense of the soup
KELL, D. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.04.012 · Cited by 529
Susceptibility of Human Metabolic Phenotypes to Dietary Modulation
Stella, C., Beckwith-Hall, B., Cloarec, O., Holmes, E., Lindon, J. C., Powell, J., van der Ouderaa, F., Bingham, S., Cross, A. J., & Nicholson, J. K. (2006) · Journal of Proteome Research · doi:10.1021/pr060265y · Cited by 376
Flagged first, then by citations
Research works printed but not linked: 84
- 10.1053/jhep.2002.34857 · DOI · Paper page
- 10.1002/hep.20948 · DOI
- 10.7326/0003-4819-137-12-200212170-00007 · DOI · Paper page
- 10.1002/hep.21424 · DOI · Paper page
- 10.2165/00002018-200932010-00005 · DOI · Paper page
- 10.1111/j.1365-2036.2007.03355.x · DOI
- 10.1016/j.jhep.2008.10.021 · DOI · Paper page
- 10.1016/j.gastro.2005.05.006 · DOI · Paper page
- 10.1038/ng.379 · DOI
- 10.1038/ng.632 · DOI
- 10.1056/nejmoa0706135 · DOI
- 10.1002/hep.26294 · DOI
- 10.1055/s-2002-30101 · DOI
- 10.1086/313680 · DOI
- 10.1002/hep.21324 · DOI
- 10.1053/j.gastro.2008.09.011 · DOI · Paper page
- 10.1016/j.cca.2008.01.018 · DOI
- 10.1038/clpt.2008.262 · DOI
- 10.1055/s-0029-1240008 · DOI
- 10.1002/hep.22633 · DOI
- 10.1289/ehp.112-a410 · DOI
- 10.1080/004982599238047 · DOI
- 10.1016/j.taap.2009.11.019 · DOI
- 10.1002/hep.22272 · DOI
- 10.1002/hep.22895 · DOI · Paper page
- 10.1002/hep.23317 · DOI
- 10.1021/tx050285z · DOI
- 10.1001/jama.296.1.87 · DOI
- 10.1016/j.cbi.2004.09.002 · DOI
- 10.1016/j.freeradbiomed.2005.08.038 · DOI
- 10.1093/toxsci/kfl180 · DOI
- 10.2174/092986709788803097 · DOI
- 10.2133/dmpk.dmpk-11-rg-005 · DOI
- 10.1021/tx800464q · DOI
- 10.1038/nrgastro.2011.22 · DOI
- 10.1124/dmd.31.12.1499 · DOI
- 10.1081/DMR-200033494 · DOI
- 10.1021/pr060513q · DOI
- 10.1016/j.jpba.2004.08.002 · DOI
- 10.1021/ac0708588 · DOI
- 10.1038/clpt.2009.240 · DOI
- 10.1038/clpt.2010.151 · DOI
- 10.1016/j.taap.2004.06.031 · DOI
- 10.1021/tx0256127 · DOI
- 10.1021/pr060024q · DOI
- 10.1021/pr0503376 · DOI
- 10.1111/j.1742-7843.2006.pto_455.x · DOI
- 10.1021/pr0601584 · DOI
- 10.1016/j.toxlet.2007.07.010 · DOI
- 10.1016/j.jchromb.2008.04.008 · DOI
- 10.1016/j.jchromb.2008.05.049 · DOI · Paper page
- 10.1016/j.jpba.2009.12.026 · DOI · Paper page
- 10.1016/j.taap.2010.07.020 · DOI · Paper page
- 10.1016/j.tox.2011.05.012 · DOI · Paper page
- 10.1177/1091581811414436 · DOI
- 10.1093/toxsci/kfr238 · DOI
- 10.1080/01926230590958146 · DOI
- 10.1021/tx800225q · DOI
- 10.1186/1471-230x-9-99 · DOI
- 10.1124/dmd.109.027565 · DOI
- 10.1016/j.tox.2008.11.018 · DOI
- 10.1021/pr9000256 · DOI
- 10.1021/pr201161f · DOI
- 10.1021/pr300297z · DOI
- 10.1038/nm.3104 · DOI
- 10.1371/journal.pone.0067451 · DOI · Paper page
- 10.1371/journal.pone.0090416 · DOI · Paper page
- 10.1371/journal.pone.0097249 · DOI · Paper page
- 10.1016/j.taap.2014.02.008 · DOI · Paper page
- 10.1016/j.csbj.2014.08.001 · DOI
- 10.1002/jat.1746 · DOI · Paper page
- 10.1016/j.toxlet.2014.07.021 · DOI · Paper page
- 10.1016/j.fct.2013.01.020 · DOI · Paper page
- 10.1016/j.taap.2015.07.016 · DOI
- 10.1016/j.jprot.2015.03.014 · DOI
- 10.1007/s11306-011-0329-9 · DOI · Paper page
- 10.1002/jat.2844 · DOI
- 10.1016/j.tox.2014.06.003 · DOI
- 10.1016/j.jprot.2014.04.008 · DOI · Paper page
- 10.1016/j.tiv.2014.12.016 · DOI
- 10.1002/elps.201500095 · DOI · Paper page
- 10.1021/ac402390q · DOI
- 10.2217/bmm.13.150 · DOI · Paper page
- 10.1016/j.jchromb.2014.08.011 · DOI
Cited by
Sorted by citations
Andújar-Vera, F., Alés-Palmer, M. L., Muñoz-de-Rueda, P., Iglesias-Baena, I., & Ocete-Hita, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713562 · Cited by 10
Metadata
- Authors
- Iruzubieta, P., Arias-Loste, M. T., Barbier-Torres, L., Martinez-Chantar, M. L., & Crespo, J.
- Affiliations
- Gastroenterology and Hepatology Department, Marqués de Valdecilla University Hospital, 39008 Santander, Spain
- CIC bioGUNE, Metabolomics Unit, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Spain
- Venue
- BioMed Research International
- Publisher
- Hindawi Limited
- Published
- 2015
- Volume
- 2015
- Pages
- 1-8
- ISSN
- 2314-6133
- 2314-6141
- PMC
- PMC4707380
- Cited by
- 24
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review